OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
March 14, 2019 17:27 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., March 14, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you own shares of Osiris Therapeutics, Inc. (NASDAQ GM: OSIR)? Did you purchase any of your shares prior to March...
EQUITY NOTICE: Rosen Law Firm Reminds Osiris Therapeutics, Inc. Investors of Important January 22, 2016 Deadline in Class Action Filed by Firm – OSIR
January 08, 2016 11:43 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Osiris Therapeutics, Inc. (NASDAQ:OSIR) securities from May 12, 2014 through...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Osiris Therapeutics, Inc. -- OSIR
December 22, 2015 14:45 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Osiris Therapeutics, Inc....
Mesoblast Unveils Path to Bring Its Key Products to Market
August 25, 2014 20:27 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 25, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported 2014 financial results and unveiled its...